Medicines Australia is proud to have been involved in the development of the Australasian Teletrial Model, including as part of the funding consortium. The model has been developed by the Clinical Oncology Society of Australia (COSA) Rural and Regional Group in consultation with clinical trial sponsors, clinicians, health administrators and regulatory bodies. While the model was initially designed to increase access to clinical trials for people with cancer living in rural and remote locations, it became apparent that the model was applicable for all clinical trials. This has become particularly significant and achievable through the rapid uptake of telehealth, which will further facilitate clinical trial activity across rural and remote locations.

Developed and piloted over three years, the COSA teletrials project has demonstrated its proof of concept, including that it can be scaled up nationally for all teletrials.  There are already many patients participating in teletrials across Australia, including in Queensland, NSW, ACT, Victoria and South Australia.

The following resources have been developed to assist sponsors and sites to establish the Teletrial Model:

APJCO supplement Implementation of the Australasian Teletrial Model: Lessons from Practice

The VCCC Teletrials Program have also developed a Teletrials Online Learning Module

The National Teletrials Compendium

The compendium consists of two publications, one covers principles and the other covers standard operating procedures for clinical trials and teletrials. The compendium has been agreed to by all states and territories and will help organisations and people who conduct clinical trials.